586 related articles for article (PubMed ID: 23877982)
1. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people.
Khunti K; Wolden ML; Thorsted BL; Andersen M; Davies MJ
Diabetes Care; 2013 Nov; 36(11):3411-7. PubMed ID: 23877982
[TBL] [Abstract][Full Text] [Related]
2. Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes.
Levin PA; Zhou S; Gill J; Wei W
J Manag Care Spec Pharm; 2015 Dec; 21(12):1172-81. PubMed ID: 26679966
[TBL] [Abstract][Full Text] [Related]
3. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
4. Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents.
Kim K; Unni S; McAdam-Marx C; Thomas SM; Sterling KL; Olsen CJ; Johnstone B; Mitchell M; Brixner D
J Manag Care Spec Pharm; 2019 Mar; 25(3):314-322. PubMed ID: 30816811
[TBL] [Abstract][Full Text] [Related]
5. Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53).
Maegawa H; Ishigaki Y; Langer J; Saotome-Nakamura A; Andersen M;
J Diabetes Investig; 2021 Mar; 12(3):374-381. PubMed ID: 32643314
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes.
Levin PA; Wei W; Zhou S; Xie L; Baser O
J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822
[TBL] [Abstract][Full Text] [Related]
7. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
10. Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs).
Desouza C; Kirk AR; Mangla KK; Wolden ML; Lingvay I
BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33376084
[TBL] [Abstract][Full Text] [Related]
11. Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.
Banerji MA; Baron MA; Gao L; Blonde L
Postgrad Med; 2014 May; 126(3):111-25. PubMed ID: 24918797
[TBL] [Abstract][Full Text] [Related]
12. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study].
Pan C; Ji L; Lu J; Yang W; Zhou Z;
Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):612-7. PubMed ID: 26359024
[TBL] [Abstract][Full Text] [Related]
14. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes.
Desai U; Kirson NY; Kim J; Khunti K; King S; Trieschman E; Hellstern M; Hunt PR; Mukherjee J
Diabetes Care; 2018 Oct; 41(10):2096-2104. PubMed ID: 30131396
[TBL] [Abstract][Full Text] [Related]
15. The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus.
Asche CV; Bode B; Busk AK; Nair SR
Diabetes Obes Metab; 2012 Jan; 14(1):47-57. PubMed ID: 21834876
[TBL] [Abstract][Full Text] [Related]
16. Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China.
Zhang L; Ji L; Guo L; Lu J; Tian H; Zhu D; Xing X; Weng JP; Jia W
Diabetes Technol Ther; 2015 Nov; 17(11):816-24. PubMed ID: 26448574
[TBL] [Abstract][Full Text] [Related]
17. Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United States.
Hoog M; Smith JL; Yu M; Peleshok J; Mody R; Grabner M
Clin Ther; 2022 Jun; 44(6):873-887. PubMed ID: 35618571
[TBL] [Abstract][Full Text] [Related]
18. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.
Janka HU; Plewe G; Busch K
J Am Geriatr Soc; 2007 Feb; 55(2):182-8. PubMed ID: 17302653
[TBL] [Abstract][Full Text] [Related]
19. The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study.
Fang HSA; Gao Q; Tan WY; Lee ML; Hsu W; Tan NC
BMC Med; 2022 Jan; 20(1):22. PubMed ID: 35078484
[TBL] [Abstract][Full Text] [Related]
20. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study.
Meneghini LF; Rosenberg KH; Koenen C; Merilainen MJ; Lüddeke HJ
Diabetes Obes Metab; 2007 May; 9(3):418-27. PubMed ID: 17391170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
